The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin Academic Article uri icon

Overview

MeSH Major

  • BCG Vaccine
  • Neoplasm Recurrence, Local
  • Urinary Bladder Neoplasms

abstract

  • Failure to repeat resection before initiating intravesical bacillus Calmette-Guérin therapy for high risk nonmuscle invasive bladder cancer significantly increases the risk of recurrence. Therefore, we believe that restaging resection should be performed before initiating bacillus Calmette-Guérin therapy in all patients with high risk nonmuscle invasive bladder cancer.

publication date

  • February 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4157345

Digital Object Identifier (DOI)

  • 10.1016/j.juro.2013.08.022

PubMed ID

  • 23973518

Additional Document Info

start page

  • 341

end page

  • 5

volume

  • 191

number

  • 2